Authors
Latest:
Costs Associated With Second-Line Therapies for Lung CancerErlotinib may confer an economic advantage for payers over docetaxel and pemetrexed for second-line treatment of lung cancer because of lower costs.
Latest:
Establishing Standards of Care for Amiodarone Monitoring in an Outpatient SettingImplementing a quality-improvement project that allows for education and interdisciplinary collaboration among pharmacists, cardiologists, and primary care providers can improve rates of amiodarone monitoring.
Latest:
Video Consults: A New Health Care EraFinding ways to help patients take their medicine as prescribed by their physician will not only help drive better health outcomes but also reduce costs.
Latest:
Joining a Pharmacy Organization Yields BenefitsGaining the most value from membership requires active participation by techs and a willingness to go outside their comfort zones.
Latest:
HIV Drug Costs Create Challenges for Patients on MedicareHIV drug prices rose 34% between 2012 and 2018 and continue to climb, which experts say is a huge issue.
Latest:
Ethical Issues in PharmacogenomicsThe clinical implementation of pharmacogenomics is an exciting area that is showing promise of enhancing the quality of patient care.
Latest:
The Role of Tyrosine Kinase Inhibitors in Non–small Cell Lung CancerThere are 5 available EGFR TKIs for the treatment of patients with EGFR-mutant lung cancers: gefitinib (Iressa), erlotinib (Tarceva), afatinib (Gilotrif), dacomitinib (Vizimpro), and osimertinib.
Latest:
Study Shows Steady Rise of Multiple Sclerosis Prevalence in United StatesThe prevalence of multiple sclerosis in the United States has steadily grown over the past 5 years to nearly 1 million people.
Latest:
Time for a Change? Looking Ahead at New Treatment Strategies for the Management of DyslipidemiaThis Continuing Education activity is supported by an educational grant from Merck Sharp & Dohme Corp.
Latest:
Impact of Patient Cost Sharing on Multiple Sclerosis TreatmentThis study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.
Latest:
US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes MellitusSaxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
Asthma: An Unrecognized Risk Factor for ShinglesHerpes zoster, also known as shingles, is a painful rash caused by a reactivation of the varicella-zoster virus, also called the chickenpox virus.
Latest:
Comparative Treatment Patterns Among Psoriasis Patients Using Adalimumab, Etanercept, or UstekinumabThis retrospective study compared the treatment patterns of ustekinumab with recommended maintenance administration every 12 weeks, with adalimumab and etanercept, administered weekly or every other week, for the treatment of plaque psoriasis.
Latest:
Baby Still "Cured" of HIVAn HIV-infected baby treated aggressively with antiretroviral therapy starting shortly after birth remains virus-free at the age of 3 years despite having ceased treatment at the age of 18 months.
Latest:
Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan ReexaminationMedicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.
Latest:
Why Pharmacists Should Recommend Asthma SpacersPharmacists should recommend asthma spacers to patients taking inhaler therapy for uncontrolled asthma because the devices can help improve hand-breath coordination while reducing side effects of inhaled medication.
Latest:
Pharmacy Benefits Manager Industry Expected to GrowDrug patent expirations may cause a significant shift in the pharmacy benefits marketplace.
Latest:
100 Years Later, Pharmacy Retains Its PastIn 1920, Johnson & Johnson created the slogan “Your Druggist is More Than a Merchant. Try the Drug Store First.”
Latest:
Looking Beyond Prescription Medications with Integrative MedicineThe Nontraditional Pharmacist podcast presents a discussion about pharmacists practicing integrative medicine and touch on the business implications of integrative medicine in the future.
Latest:
Coping with Rosacea: A Guide from Triggers to TreatmentsRosacea's symptoms can cause patients embarrassment, which pharmacists can help relive with important treatment information.
Latest:
What Are the Best Drugs to Treat Diabetes?Here are the Top 10 medications in terms of efficacy for lowering A1C and blood sugar levels.
